Biopta Ltd was founded in 2002 by Prof Chris Hillier and Dr David Bunton, with the vision to establish and maintain a dominant position as the worlds primary drug-tissue interaction specialists, based on quality and innovation in services and instrumentation.
Since 2002 we have grown considerably as both a service provider and instrument manufacturing company. Over the last 4 years we have supported a number of global pharmaceutical and biotech companies and have expanded our CRO expertise and services. In addition we have taken a new revolutionary concept and have grown this into our award wining instrument, Perf-Exion.
We have unrivalled expertise in human tissue handling and over 25 years experience in the area of in vitro pharmacology. This combined with our truly customer focussed service makes us a unique provider of human in vitro pharmacology services and instruments, the complete solution to your human tissue requirements.
Please contact us for further information, or e-mail us at info@biopta.com.
